Ursodeoxycholic Acid in Chronic Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00285597

Recruitment Status : Unknown

Verified October 2009 by National Heart and Lung Institute.
Recruitment status was: Active, not recruiting

First Posted : February 2, 2006

Last Update Posted : October 9, 2009

Sponsor:

Collaborator:

Dr. Falk Pharma GmbH

Information provided by:

National Heart and Lung Institute

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Primary Completion Date :	No date given
Study Completion Date :	January 2006

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

von Haehling S, Schefold JC, Jankowska EA, Springer J, Vazir A, Kalra PR, Sandek A, Fauler G, Stojakovic T, Trauner M, Ponikowski P, Volk HD, Doehner W, Coats AJ, Poole-Wilson PA, Anker SD. Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. J Am Coll Cardiol. 2012 Feb 7;59(6):585-92. doi: 10.1016/j.jacc.2011.10.880.

To Top